APA (7th ed.) Citation

Nagar, S., Hawi, A., Sciascia, T., & Korzekwa, K. (2024). Disposition of Oral Nalbuphine and Its Metabolites in Healthy Subjects and Subjects with Hepatic Impairment: Preliminary Modeling Results Using a Continuous Intestinal Absorption Model with Enterohepatic Recirculation. Metabolites, 14(9), 471. https://doi.org/10.3390/metabo14090471

Chicago Style (17th ed.) Citation

Nagar, Swati, Amale Hawi, Thomas Sciascia, and Ken Korzekwa. "Disposition of Oral Nalbuphine and Its Metabolites in Healthy Subjects and Subjects with Hepatic Impairment: Preliminary Modeling Results Using a Continuous Intestinal Absorption Model with Enterohepatic Recirculation." Metabolites 14, no. 9 (2024): 471. https://doi.org/10.3390/metabo14090471.

MLA (9th ed.) Citation

Nagar, Swati, et al. "Disposition of Oral Nalbuphine and Its Metabolites in Healthy Subjects and Subjects with Hepatic Impairment: Preliminary Modeling Results Using a Continuous Intestinal Absorption Model with Enterohepatic Recirculation." Metabolites, vol. 14, no. 9, 2024, p. 471, https://doi.org/10.3390/metabo14090471.